Tech Company Financing Transactions
Vivodyne Funding Round
Kairos Ventures and private investors participated in a $4 million Seed funding round for Vivodyne. This venture round closed on 3/31/2021.
Transaction Overview
Company Name
Announced On
3/31/2021
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Seed
Investors
Kairos Ventures (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3401 Grays Ferry Ave. 117
Philadelphia, PA 19146
USA
Philadelphia, PA 19146
USA
Phone
Undisclosed
Website
Email Address
Overview
Vivodyne's Pipeline V accelerates the development of cures to human diseases. Experiment on thousands of lab-grown human tissues and dissect biological complexity with superhuman AI. Vivodyne's platform cultures the most realistic human tissues ever lab-grown to answer deep questions about human health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrei Georgescu
Chief Scientific Officer
Daniel Huh
Browse more venture capital transactions:
Prev: 3/31/2021: Avvir venture capital transaction
Next: 3/31/2021: KUDO venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs